Literature DB >> 26316370

Presentation of Celiac Disease in Finnish Children Is No Longer Changing: A 50-Year Perspective.

Laura Kivelä1, Katri Kaukinen2, Marja-Leena Lähdeaho1, Heini Huhtala3, Merja Ashorn4, Tarja Ruuska5, Pauliina Hiltunen1, Jarmo Visakorpi1, Markku Mäki1, Kalle Kurppa6.   

Abstract

OBJECTIVES: To chart trends in the presentation of celiac disease in a large cohort of Finnish children diagnosed over a period of 48 years. STUDY
DESIGN: Clinical and serologic data, severity of small-bowel mucosal damage, and presence of associated conditions were gathered from 596 children diagnosed with celiac disease in 1966-2013. The children were divided into 4 groups based on the year of diagnosis (before 1980, 1980-1999, 2000-2009, and 2010-2013), and the variables were compared between the periods. The incidence of celiac disease autoimmunity in 2001-2013 was calculated based on the number of new antibody-positive cases in each year.
RESULTS: Age at diagnosis rose from median 4.3 years before 1980 to between 7.6 and 9.0 years in the later periods. The severity of clinical presentation, in general, became milder and poor growth less common during the entire study period of 50 years. Percentages of children with classical gastrointestinal presentation decreased, and those with atypical or subclinical presentation increased after the 1990s, these changes leveling off in 2000-2013. Similarly, the severity of small-bowel mucosal damage was milder after the 1990s. The incidence of celiac disease autoimmunity increased in the early 2000s but then fluctuated without a clear trend. There were no significant secular changes in sex distribution, presence of anemia, levels of celiac antibodies, or celiac disease-associated conditions.
CONCLUSIONS: The clinical and histologic presentation of celiac disease in children became milder, especially in the 1980s and 1990s. However, most of these changes have reached a plateau in recent years.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26316370     DOI: 10.1016/j.jpeds.2015.07.057

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

1.  Increasing Incidence and Altered Presentation in a Population-based Study of Pediatric Celiac Disease in North America.

Authors:  Eyad Almallouhi; Katherine S King; Bhavisha Patel; Chung Wi; Young J Juhn; Joseph A Murray; Imad Absah
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

2.  Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.

Authors:  Maureen M Leonard; Dascha C Weir; Maya DeGroote; Paul D Mitchell; Prashant Singh; Jocelyn A Silvester; Alan M Leichtner; Alessio Fasano
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

3.  Rising prevalence of celiac disease is not universal and repeated testing is needed for population screening.

Authors:  Rachel Levinson-Castiel; Rami Eliakim; Eilat Shinar; Tsachi-Tsadok Perets; Olga Layfer; Nina Levhar; Michael Schvimer; Luba Marderfeld; Shomron Ben-Horin; Raanan Shamir
Journal:  United European Gastroenterol J       Date:  2018-12-06       Impact factor: 4.623

4.  Prevalence of coexisting autoimmune thyroidal diseases in coeliac disease is decreasing.

Authors:  Patricia Dominguez Castro; Grace Harkin; Mary Hussey; Brian Christopher; Clifford Kiat; Jun Liong Chin; Valerie Trimble; Deirdre McNamara; Padraic MacMathuna; Brian Egan; Barbara Ryan; David Kevans; Mohamed Abuzakouk; Richard Farrell; Con Feighery; Valerie Byrnes; Nasir Mahmud; Ross McManus
Journal:  United European Gastroenterol J       Date:  2020-01-07       Impact factor: 4.623

5.  Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood.

Authors:  Laura Kivelä; Alina Popp; Taina Arvola; Heini Huhtala; Katri Kaukinen; Kalle Kurppa
Journal:  United European Gastroenterol J       Date:  2018-05-17       Impact factor: 4.623

6.  Effect of a Gluten-free Diet on Quality of Life in Patients With Nonclassical Versus Classical Presentations of Celiac Disease.

Authors:  Rok Seon Choung; Abhinav Lamba; Eric V Marietta; Jacalyn A See; Joseph J Larson; Katherine S King; Carol T Van Dyke; Alberto Rubio-Tapia; Joseph A Murray
Journal:  J Clin Gastroenterol       Date:  2020-08       Impact factor: 3.174

Review 7.  Current Concepts of Dermatitis Herpetiformis.

Authors:  Teea Salmi; Kaisa Hervonen
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

8.  Macrophage activation syndrome triggered by coeliac disease: a unique case report.

Authors:  J Palman; J May; C Pilkington
Journal:  Pediatr Rheumatol Online J       Date:  2016-12-09       Impact factor: 3.054

9.  The Long-Term Consumption of Oats in Celiac Disease Patients Is Safe: A Large Cross-Sectional Study.

Authors:  Katri Aaltonen; Pilvi Laurikka; Heini Huhtala; Markku Mäki; Katri Kaukinen; Kalle Kurppa
Journal:  Nutrients       Date:  2017-06-15       Impact factor: 5.717

Review 10.  Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.

Authors:  Tiina Rauhavirta; Minna Hietikko; Teea Salmi; Katri Lindfors
Journal:  Clin Rev Allergy Immunol       Date:  2019-08       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.